BeiGene | Study Comparing Zanubrutinib + Rituximab Versus Bendamustine + Rituximab in Participants With Untreated Mantle Cell Lymphoma

⟵ Back to Search Results

Study Comparing Zanubrutinib + Rituximab Versus Bendamustine + Rituximab in Participants With Untreated Mantle Cell Lymphoma

Beigene Study ID

BGB-3111-306

ClinicalTrials.gov ID

NCT04002297

EudraCT Number

2019-000413-36

China Drug Trials ID

CTR20211594

Study Overview

Sex: All

Age: 60 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 60 Years / N/A

No Study Documents